NCT00887250View on ClinicalTrials.gov

A Study to Investigate the Antihypertensive Efficacy of MK0954

PHASE3CompletedINTERVENTIONAL
Enrollment

366

Participants

Timeline

Start Date

December 31, 1991

Primary Completion Date

August 31, 1992

Study Completion Date

November 30, 1992

Conditions
Hypertension
Interventions
DRUG

losartan potassium

50 mg Losartan (MK0954) tablet taken once daily for 12 weeks.

DRUG

Comparator: losartan

50 mg tablet of Losartan (MK0954) taken once daily for 6 weeks, Non-responders will then have the dose up titrated to 100 mg for remaining 6 weeks.

DRUG

Comparator: Placebo

Placebo to Losartan

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00887250 - A Study to Investigate the Antihypertensive Efficacy of MK0954 | Biotech Hunter | Biotech Hunter